Blueprint Medicines | ARS:年度报告
04/25 17:31 (美东)
Blueprint Medicines | DEF 14A:股东委托书决议
04/25 17:26 (美东)
Blueprint Medicines | 8-K:重大事件
04/25 08:35 (美东)
Blueprint Medicines | SC 13G/A:超过5%持股股东披露文件(修正)-T. ROWE PRICE ASSOCIATES, INC.(10.2%)
04/10 13:02 (美东)
Blueprint Medicines | 4:持股变动声明-高管 Landsittel Michael
04/01 16:42 (美东)
Blueprint Medicines | 144:拟议出售证券
03/28 18:00 (美东)
Blueprint Medicines | 4:持股变动声明-董事 Albers Jeffrey W.
03/26 21:15 (美东)
Blueprint Medicines | 4:持股变动声明-董事 Albers Jeffrey W.
03/22 17:53 (美东)
Blueprint Medicines | 4:持股变动声明-高管 Landsittel Michael
03/19 17:13 (美东)
Blueprint Medicines | 4:持股变动声明-高管 Hurley Ariel
03/19 16:54 (美东)
Blueprint Medicines | 144:拟议出售证券
03/15 17:27 (美东)
Blueprint Medicines | 144:拟议出售证券
03/15 16:52 (美东)
Blueprint Medicines | 4:持股变动声明-高管 Lee Philina
03/15 16:52 (美东)
Blueprint Medicines | 144:拟议出售证券
03/13 16:24 (美东)
Blueprint Medicines | 4:持股变动声明-高管 Hewes L. Becker
03/11 18:33 (美东)
Blueprint Medicines | 4:持股变动声明-高管 Durso-Bumpus Debra
03/11 18:33 (美东)
Blueprint Medicines | 4:持股变动声明-高管 Haviland Kate
03/11 18:28 (美东)
Blueprint Medicines | 4:持股变动声明-高管 Lee Philina
03/11 18:28 (美东)
Blueprint Medicines | 4:持股变动声明-高管 Murray Christopher K.
03/11 18:28 (美东)
Blueprint Medicines | 4:持股变动声明-高管 Landsittel Michael
03/11 18:28 (美东)
暂无数据
暂无数据